A new model to monitor the virological efficacy of antiretroviral treatment in resource-poor countries

This publication has 62 references indexed in Scilit:

• Evaluation of a Low Cost Reverse Transcriptase Assay for Plasma HIV-1 Viral Load Monitoring
  Current HIV Research, 2005
• Evaluation of Two Commercially Available, Inexpensive Alternative Assays Used for Assessing Viral Load in a Cohort of Human Immunodeficiency Virus Type 1 Subtype C-Infected Patients from South Africa
  Journal of Clinical Microbiology, 2005
• Use of Viral Load Measured After 4 Weeks of Highly Active Antiretroviral Therapy to Predict Virologic Outcome at 24 Weeks for HIV-1???Positive Individuals
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 2004
• HIV-1 p24 Antigen Is a Significant Inverse Correlate of CD4 T-Cell Change in Patients With Suppressed Viremia Under Long-Term Antiretroviral Therapy
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 2003
• A new quantitative HIV load assay based on plasma virion reverse transcriptase activity for the different types, groups and subtypes
  AIDS, 2003
• Monitoring HIV treatment in the developing world.
  The Lancet Infectious Diseases, 2002
• Cheaper HIV drugs for poor nations bring a new challenge: monitoring treatment.
  JAMA, 2002
• Comparison of an Assay Using Signal Amplification of the Heat-Dissociated p24 Antigen with the Roche Monitor Human Immunodeficiency Virus RNA Assay
  Journal of Clinical Microbiology, 2002
• Antiretroviral treatment monitoring with an improved HIV‐1 p24 antigen test: an inexpensive alternative to tests for viral RNA
  Journal of Medical Virology, 2001
• Human Immunodeficiency Virus Type 1 p24 Concentration Measured by Boosted ELISA of Heat‐Denatured Plasma Correlates with Decline in CD4 Cells, Progression to AIDS, and Survival: Comparison with Viral RNA Measurement
  The Journal of Infectious Diseases, 2000